Autres langues Illumina, Inc.

Actions

Temps réel estimé Cboe BZX Autres places de cotation 15:50:44 20/05/2024			Varia. 5j.	Varia. 1 janv.
110,7 ^USD	-0,35 %		-2,23 %	-20,82 %

15/05	ILLUMINA, INC. : Daiwa Securities est neutre	ZM
14/05	Transcript : Illumina, Inc. Presents at 2024 RBC Capital Markets Global Healthcare Conference, May-14-2024 08:30 AM

Illumina To Webcast Upcoming Investor Conference	15/05
Devyser Diagnostics AB publishes quarterly report for the period January to March 2024	08/05
Illumina Files Registration Statement for Planned GRAIL Divestiture	07/05
Illumina publicly files Form 10 registration statement ahead of planned divestiture of GRAIL	07/05
Illumina to Webcast Upcoming Investor Conference	06/05
I titoli di Wall Street da tenere d'occhio (aggiornamento)	03/05
Illumina To Webcast Upcoming Investor Conference	03/05
EE.UU. - Valores a seguir en Wall Street (actualizado)	03/05
Illumina : First Quarter 2024 Prepared Remarks	03/05
Illumina reaffirms annual revenue forecast over continued sluggish demand	03/05
Illumina Q1 Non-GAAP Earnings Increase, Revenue Decreases -- Shares Down After Hours	02/05
Illumina: Q1 Earnings Snapshot	02/05
Earnings Flash (ILMN) ILLUMINA Posts Q1 EPS $0.09, vs. Street Est of $0.10	02/05
Earnings Flash (ILMN) ILLUMINA Posts Q1 Revenue $1.08B, vs. Street Est of $1.05B	02/05
Illumina, Inc. Reaffirms Earnings Guidance for the Fiscal Year 2024	02/05
Illumina, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024	02/05
Illumina : 2024 Assurance Statement	23/04
RECOMENDACIONES DE LOS ANALISTAS EE.UU./UK : AMD, Colgate, Fair Isaac, Tyson Foods, AstraZeneca	16/04
ANALYST RECOMMENDATIONS : AMD, Colgate, Fair Isaac, Tyson Foods, AstraZeneca	16/04
Illumina's planned divestment of GRAIL approved by the European Commission	15/04

Aucun résultat pour cette recherche